A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E and beta carotene for age-related cataract and vision loss: AREDS report no. 9
about
Meta-regression analyses, meta-analyses, and trial sequential analyses of the effects of supplementation with beta-carotene, vitamin A, and vitamin E singly or in different combinations on all-cause mortality: do we have evidence for lack of harm?Cholesterol-enriched diet causes age-related macular degeneration-like pathology in rabbit retinaAntioxidant vitamin supplementation for preventing and slowing the progression of age-related cataractAntioxidant supplements for prevention of mortality in healthy participants and patients with various diseasesAntioxidant supplementation for preventing and slowing the progression of age-related cataractVitamin E supplementation and macular degeneration: randomised controlled trial.A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8Lutein, Zeaxanthin, and meso-Zeaxanthin in the Clinical Management of Eye DiseaseRecent developments in multivitamin/mineral researchCataract prevalence and prevention in Europe: a literature reviewAge-related changes in the kinetics of human lenses: prevention of the cataractA review of the epidemiological evidence for the 'antioxidant hypothesis'Drusen, choroidal neovascularization, and retinal pigment epithelium dysfunction in SOD1-deficient mice: a model of age-related macular degenerationThe ERCC6 gene and age-related macular degenerationDietary supplements and disease prevention - a global overview.Increased vitamin plasma levels in Swedish military personnel treated with nutrients prior to automatic weapon training.Nutrient plasma levels achieved during treatment that reduces noise-induced hearing loss.Genistein and genistein-containing dietary supplements accelerate the early stages of cataractogenesis in the male ICR/f rat.Using current data to define new approach in age related macular degeneration: need to accelerate translational research.Mining Retrospective Data for Virtual Prospective Drug Repurposing: L-DOPA and Age-related Macular DegenerationAntioxidants in prevention of cataracts in South India: methodology and baseline data*.Scanning laser entoptic perimetry for the detection of age-related macular degeneration.Sodium Iodate Produces a Strain-Dependent Retinal Oxidative Stress Response Measured In Vivo Using QUEST MRI.Pegaptanib sodium for the treatment of neovascular age-related macular degeneration.Modelling the natural history of geographic atrophy in patients with age-related macular degeneration.Persimmon Leaves (Diospyros kaki) Extract Protects Optic Nerve Crush-Induced Retinal Degeneration.At the frontier of vision research: the National Eye Institute celebrates 40 yearsVisual acuity after cataract surgery in patients with age-related macular degeneration: age-related eye disease study 2 report number 5.The Effect of a Mediterranean Diet on the Incidence of Cataract SurgeryAscorbic acid concentrations in aqueous humor after systemic vitamin C supplementation in patients with cataract: pilot study.Antioxidant defenses in the ocular surface.Dietary carbohydrate in relation to cortical and nuclear lens opacities in the melbourne visual impairment project.Topical nutraceutical Optixcare EH ameliorates experimental ocular oxidative stress in rats.Nutrition effects on ocular diseases in the aging eye.Vitamin C as an antioxidant: evaluation of its role in disease prevention.Dry age-related macular degeneration: A currently unmet clinical need.Plasma oxidized LDL and thiol-containing molecules in patients with exudative age-related macular degeneration.Efficacy of Multivitamin/mineral Supplementation to Reduce Chronic Disease Risk: A Critical Review of the Evidence from Observational Studies and Randomized Controlled Trials.Visual prosthetic device for bilateral end-stage macular degeneration.Visual acuity outcomes after cataract surgery in patients with age-related macular degeneration: age-related eye disease study report no. 27
P2860
Q21090716-BBD0BCAF-117A-43BB-8089-A29A2C6D1A5BQ21260371-2C8716DC-CF43-455C-8330-039B19C0E7E1Q24202693-2063F5A3-FF70-43AC-BF3F-14C1F32AF465Q24242944-95E1E1A0-0D13-4F52-91B1-ED1C1AFFFFC0Q24247524-BEE5A5AF-6670-47AC-A795-4B8C843ED1F6Q24531484-4F34C8A3-5876-4E6D-BA48-4BEA4BFD3C53Q24544001-B3B4C1A4-1004-484C-8D42-EAAA911E3C7EQ26773085-71E20D61-6B78-4C74-AEDC-0DAA6E79FDA3Q26849381-C7DDB256-EFAA-41BA-B0A0-F934AE8C584CQ26862582-12749FC0-0111-48B3-A623-0781057EF6F6Q28071361-E9A2A33F-13C5-4715-8BF1-595D56184B10Q28262560-D00300AF-8063-4E87-8DC7-507B2B685EF0Q28590177-8E8B66BF-8E1C-4E7B-B54A-88E5DE000E5DQ28748643-B374B56C-BDF4-4542-B07E-57C0C9A4B44AQ30251418-CB8F5B94-04DF-4DD9-83E0-928BED8708AEQ30448959-BF8187E8-C136-43C6-8C3E-6DCC30407DABQ30466285-0A025A34-74CF-4E45-9D35-60C9E8371F4DQ30498113-6F054B9F-786E-49E9-BEB9-571E874C607EQ30843382-7CE2FE2C-6A0F-4702-94D8-DD0C975521BEQ31015035-3BECD93B-9C3A-4408-A0B4-D27972A324D4Q31035634-6D5C1F89-A97F-47ED-85C3-C307A5D6320CQ31126206-A5245E65-E59B-4541-8C60-7F28CD759A1CQ32172918-29C679C2-C5DC-40B6-A26F-DB944E954B2BQ33216197-1484E273-286D-42E3-9B67-0EDD80C635FAQ33227050-EDD8E2B4-5409-47A4-9853-FE5F8FD91658Q33582677-136A6F7C-8B91-4C72-BBE2-6A5B944C8014Q33708448-9DF76052-0948-420F-B94A-41C911E761CDQ33717538-78EEA006-EF06-4F66-93E0-3B185F5D6002Q33749282-0038D33F-9FCC-4103-85C4-28F530369914Q33892164-5937AE40-B3C8-4A07-A361-C26331B37358Q33925466-9502E721-A2B0-4743-9C14-80419419AAEDQ33938168-FB68A6E8-11F0-40E5-9403-DEB91BF2E8ACQ34116939-AD0729A6-3366-4106-A1CC-18F15E8EE19CQ34132062-EAC72AD7-6B34-4F03-8C0E-E00D48C25503Q34175262-0F5DA39A-E2BA-4708-B11D-C9662C12FC98Q34378033-4F4BEA27-8DCC-42F3-AFDD-F7EE80C3D82DQ34396842-DE726313-D828-43B5-ABEF-E35C9D430CF9Q34425459-69600EF3-A42D-4169-92FF-C04D209F9CC6Q34468393-035A5349-85E6-4140-B0C6-100984CF9536Q34493282-42E1B029-04B1-4820-95DD-2EC9274D7409
P2860
A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E and beta carotene for age-related cataract and vision loss: AREDS report no. 9
description
2001 nî lūn-bûn
@nan
2001 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
A randomized, placebo-controll ...... ision loss: AREDS report no. 9
@ast
A randomized, placebo-controll ...... ision loss: AREDS report no. 9
@en
A randomized, placebo-controll ...... ision loss: AREDS report no. 9
@nl
type
label
A randomized, placebo-controll ...... ision loss: AREDS report no. 9
@ast
A randomized, placebo-controll ...... ision loss: AREDS report no. 9
@en
A randomized, placebo-controll ...... ision loss: AREDS report no. 9
@nl
prefLabel
A randomized, placebo-controll ...... ision loss: AREDS report no. 9
@ast
A randomized, placebo-controll ...... ision loss: AREDS report no. 9
@en
A randomized, placebo-controll ...... ision loss: AREDS report no. 9
@nl
P2860
P921
P3181
P1433
P1476
A randomized, placebo-controll ...... ision loss: AREDS report no. 9
@en
P2860
P304
P3181
P356
10.1001/ARCHOPHT.119.10.1439
P407
P577
2001-10-01T00:00:00Z